• 1. Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, P.R.China;
  • 2. Beijing University of Chinese Medicine, Beijing 100029, P.R.China;
LIU Yan, Email: liuyantcm@163.com; SHANG Hongcai, Email: shanghongcai@126.com
Export PDF Favorites Scan Get Citation

Dyspnea is the most common symptom in patients with acute heart failure syndrome (AHFS), and relieving dyspnea is an important goal in clinical practice, clinical trials and new drug regulatory approval. However, in clinical and scientific research, there is still no consensus on how to evaluate dyspnea, and there is still a lack of unified measurement methods. This article introduces the pathophysiological mechanism of dyspnea in acute heart failure, the measuring time of dyspnea, the posture of patients during measurement, the measuring conditions, and the common measurement methods of dyspnea in clinical trials and their advantages and disadvantages, so as to provide references for the selection of measurement methods of dyspnea in clinical trials of acute heart failure.

Citation: ZHANG Jingjing, LIU Yan, ZHANG Xiaoyu, CHEN Ying, SHANG Hongcai. Measurement methods of dyspnea in clinical trials of acute heart failure. Chinese Journal of Evidence-Based Medicine, 2020, 20(11): 1334-1339. doi: 10.7507/1672-2531.202004180 Copy

  • Previous Article

    Chinese herb injections for viral pneumonia: an overview of systematic reviews
  • Next Article

    Interpretation of COSMIN risk of bias checklist in evaluating risk of bias of studies on reliability, measurement error and criteria validity of patient-reported outcome measures